New Key Statistics Module, Z-Score and F-Score
NAS:TCRX Key Ratios
| Market Cap $ M | 291.89 |
| Enterprise Value $ M | 85.28 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.14 |
| Price/Sales | 43.05 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 12.00 |
| EPS (TTM) $ | -0.95 |
| Beneish M-Score | -4.1 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.85 |
| EV-to-EBITDA | -0.89 |
| PEG | -- |
| Shares Outstanding M | 52.97 |
| Net Margin (%) | -855.84 |
| Operating Margin % | -914.69 |
| Pre-tax Margin (%) | -855.84 |
| Quick Ratio | 7.77 |
| Current Ratio | 7.77 |
| ROA % (ttm) | -34.89 |
| ROE % (ttm) | -58.75 |
| ROIC % (ttm) | -110.66 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.29 |
TCRX Number of Guru Trades
TCRX Volume of Guru Trades
Gurus Latest Trades with NAS:TCRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TCRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TScan Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TCRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers